Skip to main content
Skip to main navigation
Search for :
Product Development Strategy
Early Clinical Development
Phase I/IIa Clinical Trials
Phase II/III Clinical Trials
Interventional Phase IIIb/Phase IV Clinical Trials
Observational Research & Registries
Product Launch & Management
Market Access Solutions
Strategic Sales Outsourcing
Biopharmaceutical Sales & Marketing
Healthcare Payers & Providers
Medical Device & Diagnostics
Public Health & Government
Small to Mid-Sized Biopharma
Specialty Clinical Associations and Patient Organizations
Central Nervous System
Diabetes & Endocrinology
Early Phase Oncology
Public Health Interest
Other Therapeutic Areas
Ethics & Compliance
Phone:+1 866 267 4479
Request a Proposal
Phone:400 881 0237
Phone:01 208 94 060
Phone:+44 203 564 4649
To develop and launch new cancer therapies, you need a collaborative partner that understands your specific challenges and the broader oncology landscape. From molecular pathways, biomarker identification and early phase trials to regulatory submission and product launch, Quintiles can help you across the lifecycle, from designing your trials and finding the right patients, to gaining regulatory approval and accelerating market adoption.
With services spanning Phase I to commercialization, we helped develop or commercialize all of the 45 top-selling oncology drugs of 2012. How can we help you achieve real results for your oncology program? With experience in virtually all major cancer indications, we integrate deep scientific and therapeutic insights to help optimize your development strategy. Combining that with our unmatched operational expertise, we can extend the capabilities of your oncology teams across the product lifecycle – and across the globe. The result: Increased probability of gathering the right data to support product utility, regulatory approval and commercial uptake.
With industry expertise and Genomic Know-How, EA| Quintiles, advances science from understanding the human genome and disease biology to detecting the effects of therapies and creating opportunities for those who can leverage new techniques and technologies.
Sharper Oncology Focus: Refining your Biomarker Strategy for Targeted Therapies
Quintiles Oncology COE can improve your probability of diagnostic and drug co-development with targeted therapies through scientific expertise, laboratory capabilities, and commercial insight.
View this video to see how
The Oncology Center of Excellence
By combining knowledge with data-driven insights, we help Pharma add value throughout the product lifecycle helping to reduce study cycle times, optimize costs, and ultimately increase the probability of regulatory and market success.
Watch To Find Out How
Maximizing Quality and Efficiency of Go/No Go Decisions in Early Oncology Development
Setting the right course early in oncology development is critical. In a webcast archive, leading oncology experts provide insights into the current R&D challenges in oncology and key success criteria for Phase I oncology studies.
Download the webcast
Achieving Real Results in Oncology
Quintiles brings together experienced oncology teams and integrated global trial operations to help our customers achieve real results in oncology clinical development.
View more Quintiles perspectives on genomics, the role of technology, and demonstrating value in oncology.
The Power of Integration in Oncology
Quintiles is partnering early with oncology drug developers, providing integrated services spanning Phase 1 through commercialization to help them achieve real results in their oncology programs. By combining scientific and therapeutic expertise with operational insights, we can gather evidence needed to support clinical utility, help gain regulatory approval, and accelerate market adoption. As a testament to our commitment, we helped develop or commercialize the world’s top 45 best-selling oncology drugs of 2012.